SPARC achieves enrollment goal in PROSEEK Phase 2 Parkinson’s trial
Sun Pharma Advanced Research Company Ltd. (SPARC) has announced the successful completion of patient enrollment for the PROSEEK study, a significant global Phase 2 clinical trial focusing on early Parkinson’s disease. This large-scale study has successfully enrolled 506 patients across 84 sites in the United States, Europe, and India, positioning it among the most extensive […]